Grantham, Mayo, Van Otterloo & Co (GMO)
ADNT icon

Grantham, Mayo, Van Otterloo & Co (GMO)’s Adient ADNT Stock Holding History

Grantham, Mayo, Van Otterloo & Co (GMO)’s Portfolio ADNT Stock Details ADNT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-13,526
Closed -$598K – 705
2021
Q1 		$598K Buy
+13,526
New +$511K ﹤0.01% 670

Other funds holding ADNT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
LAM
Lyrical Asset Management New York $7.88B AUM 36.5% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $34.3B AUM 22.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return

Grantham, Mayo, Van Otterloo & Co (GMO)'s ADNT Position: Q2 2021 in Review

Grantham, Mayo, Van Otterloo & Co (GMO) sold out of Adient (ADNT) in Q2 2021, closing a stake of 13,526 shares — an estimated $598K sold.

Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in ADNT in Q1 2021 and held it in 1 quarter. The position peaked at $598K in Q1 2021. 290 funds tracked by Wall St. Rank hold ADNT as of Q2 2021.

  • Grantham, Mayo, Van Otterloo & Co (GMO) reported no remaining Adient position as of Q2 2021 after selling out during the quarter.
  • Grantham, Mayo, Van Otterloo & Co (GMO) sold 13,526 Adient shares in Q2 2021, an estimated $598K.
  • Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in Adient in Q1 2021 and held it in 1 quarter.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s Adient position peaked at $598K in Q1 2021.
  • 290 funds tracked by Wall St. Rank held Adient as of Q2 2021.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q2 2021, filed 12 Aug 2021.